Apnex Clinical Study of the Hypoglossal Nerve Stimulation (HGNS®) System to Treat Obstructive Sleep Apnea
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01446601 |
Recruitment Status
:
Terminated
First Posted
: October 5, 2011
Last Update Posted
: April 15, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obstructive Sleep Apnea | Device: Hypoglossal Nerve Stimulation (HGNS) System (Apnex Medical ) | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 132 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Pivotal Study of the Apnex Medical™ Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea |
Study Start Date : | August 2011 |
Actual Primary Completion Date : | August 2013 |
Actual Study Completion Date : | August 2013 |

Arm | Intervention/treatment |
---|---|
Experimental: Treatment
The Treatment Arm is implanted with the HGNS System and therapy is turned on at 1 month post-implant.
|
Device: Hypoglossal Nerve Stimulation (HGNS) System (Apnex Medical )
The HGNS System in an investigational device that includes three implantable components: a neurostimulator, a stimulation lead, and a respiration sensing lead. The HGNS System is designed to activate the muscles in the upper airway to help keep the airway open during sleep. The HGNS System is intended for the treatment of moderate to severe OSA in individuals that have failed or do not tolerate positive airway pressure (PAP) therapy.
|
Control
The Control Arm is implanted with the HGNS System and therapy is turned on at 7 months post-implant.
|
Device: Hypoglossal Nerve Stimulation (HGNS) System (Apnex Medical )
The HGNS System in an investigational device that includes three implantable components: a neurostimulator, a stimulation lead, and a respiration sensing lead. The HGNS System is designed to activate the muscles in the upper airway to help keep the airway open during sleep. The HGNS System is intended for the treatment of moderate to severe OSA in individuals that have failed or do not tolerate positive airway pressure (PAP) therapy.
|
- Reduction in OSA Severity [ Time Frame: from Baseline to 6 Months ]The proportion of subjects that experience clinically meaningful improvement in AH1 (reduction >50% and AHI <20) and ODI 4% (reduction >= 25% or ODI 4% <5)from Baseline to 6 Months will be significantly greater in the Treatment Group compared to the Control Group
- Long-term Reduction in OSA Severity [ Time Frame: 12 months ]The proportion of subjects in the Treatment Group that experience clinically relevant improvement in AHI (reduction >50% and AHI <20) and ODI 4% (reduction >=25% or ODI 4% <5 at 12 months compared to Baseline.
- Safety Analysis [ Time Frame: 12 months ]Description of all adverse events

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years to 80 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 21 to 80 years
- Body mass index (BMI) ≤ 35 kg/m²
- Previously diagnosed with Moderate to severe OSA
- Individual has failed or does not tolerate PAP therapy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01446601
United States, Kansas | |
MidAmerica Neuroscience Research Institute | |
Lenexa, Kansas, United States, 66214 | |
Veritas Clinical Specialties | |
Topeka, Kansas, United States, 66606 | |
United States, Kentucky | |
Kentucky Research Group | |
Louisville, Kentucky, United States, 40217 | |
United States, Maryland | |
The Center for Sleep and Wake Disorders | |
Chevy Chase, Maryland, United States, 20815 | |
United States, Michigan | |
Henry Ford Hospital | |
Detroit, Michigan, United States, 48202 | |
United States, Minnesota | |
University of Minnesota | |
Minneapolis, Minnesota, United States, 55454 | |
United States, Missouri | |
St. Lukes Hospital | |
St. Louis, Missouri, United States, 63017 | |
United States, New York | |
Clinilabs | |
New York, New York, United States, 10019 | |
United States, North Carolina | |
Wilmington Medical Research | |
Wilmington, North Carolina, United States, 28401 | |
United States, Ohio | |
Community Research | |
Cincinnati, Ohio, United States, 45230 | |
United States, South Carolina | |
Sleep Med of South Carolina | |
Columbia, South Carolina, United States, 29201 | |
United States, Texas | |
Sleep Therapy and Research Center | |
San Antonio, Texas, United States, 78229 | |
Australia, New South Wales | |
Westmead Hospital | |
Sydney, New South Wales, Australia, 2145 | |
Australia, Victoria | |
IBAS, The Austin Hospital | |
Melbourne, Victoria, Australia, 3084 |
Responsible Party: | Apnex Medical, Inc. |
ClinicalTrials.gov Identifier: | NCT01446601 History of Changes |
Other Study ID Numbers: |
CLP-005 IDE #G090014 ( Other Identifier: FDA ) |
First Posted: | October 5, 2011 Key Record Dates |
Last Update Posted: | April 15, 2015 |
Last Verified: | December 2011 |
Keywords provided by Apnex Medical, Inc.:
Apnea OSA Sleep Apnea Syndromes Sleep Apnea, Obstructive |
Hypoglossal Nerve Stimulation Sleep Disorders Tongue |
Additional relevant MeSH terms:
Apnea Sleep Apnea Syndromes Sleep Apnea, Obstructive Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory |
Signs and Symptoms Sleep Disorders, Intrinsic Dyssomnias Sleep Wake Disorders Nervous System Diseases |